enVVeno Medical (NVNO) EPS (Weighted Average and Diluted) (2022 - 2026)
enVVeno Medical's quarterly EPS (Weighted Average and Diluted) came in at -$5.89 in Q1 2026, up 24.0% year-on-year from -$4.75 in Q1 2025, and up 81.75% quarter-over-quarter from -$32.28 in Q4 2025.
enVVeno Medical has reported EPS (Weighted Average and Diluted) for 5 years, with the latest figure at -$5.89 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 24.0% year-over-year to -$5.89; the trailing twelve-month figure through Mar 2026 stood at -$38.73 (up 25.48% YoY), and the FY2025 full-year result was -$33.06, up 25.76% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$5.89, up from -$32.28 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.23 in Q3 2025, with the low at -$43.56 in Q4 2024.
- Average EPS (Weighted Average and Diluted) over 5 years is -$5.92, with a median of -$0.55 recorded in 2022.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 46.55% in 2024, while the deepest fall reached 13512.5% in 2024.
- Tracing NVNO's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.55 in 2022, then jumped by 41.82% to -$0.32 in 2023, then slumped by 13512.5% to -$43.56 in 2024, then grew by 25.9% to -$32.28 in 2025, then surged by 81.75% to -$5.89 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$5.89 (Q1 2026), -$32.28 (Q4 2025), and -$0.23 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - | -5.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.89 |
| Dec 31, 2025 | -32.28 |
| Sep 30, 2025 | -0.23 |
| Jun 30, 2025 | -0.33 |
| Mar 31, 2025 | -7.75 |
| Dec 31, 2024 | -43.56 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.31 |
| Mar 31, 2024 | -0.31 |
| Dec 31, 2023 | -0.32 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.58 |
| Mar 31, 2023 | -0.57 |
| Dec 31, 2022 | -0.55 |
| Sep 30, 2022 | -0.54 |
| Jun 30, 2022 | -0.63 |